Domb Abraham Projects

Results Found (10)
Technology NameBriefcaseLead Researcher
Background Emulsification in aqueous media is not effective for the encapsulation of hydrophilic drugs. Peptides and proteins may deteriorate when exposed to aqueous-organic interfaces Neuropeptides are potent CNS neuromodulators and have many ...
More
Domb Abraham
  Additional information will be provided upon request
More
Domb Abraham
Additional information will be provided upon request
More
Avraham Yosefa
  Additional information will be provided upon request
More
Domb Abraham
  Our Innovation: Drug-eluting stents (DES) are widely used in intravascular intervention. The current technology is based on crystallization of drug onto stent surface (with no- polymer) Coating process is resulting in high yield coatings that ...
More
Domb Abraham
Background  Micro-emulsions are formed more or less spontaneously when their components are brought into contact.  They have been the only successful delivery systems for certain types of pharmaceutical compounds, particularly compounds such as ...
More
Domb Abraham
Background Emulsification in aqueous media is not effective for the encapsulation of hydrophilic drugs. Peptides and proteins may deteriorate when exposed to aqueous-organic interfaces Neuropeptides are potent CNS neuromodulators and have many ...
More
Domb Abraham
Company Name Aferrix Company Founders Prof. Zvi Ioav Cabantchik, Current CEO Yael Furman, Ms.C., MBA, CEO About the Company Aferrix is an innovative leader in development and applications of novel tools for early diagnosis and monitoring of ...
More
Cabantchik Ioav
Background        Many of today’s leading compounds and drugs in pipeline fail to reach clinical stages due to poor oral bioavailability. In addition, Increase in oral bioavailability leads a lower inter and intra subject variability. Our ...
More
Domb Abraham
  Additional information will be provided upon request
More
Domb Abraham